UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Systemic lactose intolerance: a new perspective on an old problem

Postgraduate Medical Journal, 2005-03, Vol.81 (953), p.167-173

2005

Volltextzugriff (PDF)

Association of lactose sensitivity with inflammatory bowel disease – demonstrated by analysis of genetic polymorphism, breath gases and symptoms

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (7), p.735-746

2011

Volltextzugriff (PDF)

Quantifying the ‘hidden’ lactose in drugs used for the treatment of gastrointestinal conditions

Alimentary pharmacology & therapeutics, 2009-03, Vol.29 (6), p.677-687

2009

Volltextzugriff (PDF)

Measurement of proteases using chemiluminescence-resonance-energy-transfer chimaeras between green fluorescent protein and aequorin

Biochemical journal, 2001-08, Vol.357 (Pt 3), p.687-697

2001

Volltextzugriff (PDF)

Association of lactose sensitivity with inflammatory bowel disease - demonstrated by analysis of genetic polymorphism, breath gases and symptoms: Lactose sensitivity and inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (7), p.735-746

2011

Volltextzugriff (PDF)

Lactose content of gastrointestinal drugs; does it matter? authors’ reply

Alimentary pharmacology & therapeutics, 2009-06, Vol.29 (11), p.1213-1213

2009

Volltextzugriff (PDF)

Engineering the C-terminus of firefly luciferase as an indicator of covalent modification of proteins

Biochimica et biophysica acta, 1996-01, Vol.1292 (1), p.89-98

1996

Volltextzugriff (PDF)

Engineering bioluminescent probes as indicators of covalent modification of proteins

Jenkins-Waud, J P

2003

Volltextzugriff (PDF)

Novel Boron-Containing, Nonclassical Antifolates: Synthesis and Preliminary Biological and Structural Evaluation

Journal of medicinal chemistry, 2007-07, Vol.50 (14), p.3283-3289

2007

Volltextzugriff (PDF)

Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase

Cancer gene therapy, 2011-06, Vol.18 (6), p.390-398

2011

Volltextzugriff (PDF)

Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase

Cancer gene therapy, 2003-01, Vol.10 (1), p.23-29

2003

Volltextzugriff (PDF)

Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (18), p.6610-6615

2004

Volltextzugriff (PDF)

Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy

Human gene therapy, 2005-03, Vol.16 (3), p.339-347

2005

Volltextzugriff (PDF)

SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (18), p.6700-6706

2004

Volltextzugriff (PDF)

A long-acting suicide gene toxin, 6-methylpurine, inhibits slow growing tumors after a single administration

The Journal of pharmacology and experimental therapeutics, 2003-03, Vol.304 (3), p.1280

2003

Volltextzugriff (PDF)

Lactose in drugs: avoided or allowed to lactose maldigesters? authors’ reply

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (8), p.925-926

2010

Volltextzugriff (PDF)

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase

Human gene therapy, 1997-09, Vol.8 (14), p.1637-1644

1997

Volltextzugriff (PDF)

DESIGN AND EVALUATION OF 5′-MODIFIED NUCLEOSIDE ANALOGS AS PRODRUGS FOR AN E. COLI PURINE NUCLEOSIDE PHOSPHORYLASE MUTANT

Nucleosides, nucleotides & nucleic acids, 2005-01, Vol.24 (5-7), p.387-392

2005

Volltextzugriff (PDF)

Antimitotic agents: structure-activity studies with some pyridine derivatives

Journal of medicinal chemistry, 1992-10, Vol.35 (20), p.3686-3690

1992

Volltextzugriff (PDF)

Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)

Biochemical pharmacology, 1995-06, Vol.50 (1), p.111-122

1995

Volltextzugriff (PDF)

Preclinical antitumor activity of bizelesin in mice

Clinical cancer research, 1996-07, Vol.2 (7), p.1143-1149

1996

Volltextzugriff (PDF)

Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain

Cancer research (Chicago, Ill.), 1991-04, Vol.51 (8), p.1979-1983

1991

Volltextzugriff (PDF)

Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis

Cancer research (Chicago, Ill.), 1987-03, Vol.47 (6), p.1621-1626

1987

Volltextzugriff (PDF)

Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia

Cancer chemotherapy and pharmacology, 1991-11, Vol.27 (6), p.456-463

1991

Volltextzugriff (PDF)

Antitumor activity of 2-chloroethyl (methylsulfonyl)methanesulfonate (clomesone, NSC 338947) against selected tumor systems in mice

Cancer research (Chicago, Ill.), 1989-03, Vol.49 (5), p.1182-1186

1989

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(34)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(24)
Animals
(21)
Mice
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Humans
(15)
Pharmacology. Drug Treatments
(14)
Antineoplastic Agents
(11)
Oncology
(9)
Pharmacology & Pharmacy
(9)
Chemotherapy
(8)
Mice, Nude
(8)
Antineoplastic Agents - Therapeutic Use
(7)
Cell Line, Tumor
(6)
Escherichia Coli - Enzymology
(6)
Female
(6)
Mice, Inbred Dba
(6)
Neoplasm Transplantation
(6)
Neoplasms, Experimental - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systemic lactose intolerance: a new perspective on an old problem

Association of lactose sensitivity with inflammatory bowel disease – demonstrated by analysis of genetic polymorphism, breath gases and symptoms

Quantifying the ‘hidden’ lactose in drugs used for the treatment of gastrointestinal conditions

Measurement of proteases using chemiluminescence-resonance-energy-transfer chimaeras between green fluorescent protein and aequorin

Association of lactose sensitivity with inflammatory bowel disease - demonstrated by analysis of genetic polymorphism, breath gases and symptoms: Lactose sensitivity and inflammatory bowel disease

Lactose content of gastrointestinal drugs; does it matter? authors’ reply

Engineering the C-terminus of firefly luciferase as an indicator of covalent modification of proteins

Engineering bioluminescent probes as indicators of covalent modification of proteins

Novel Boron-Containing, Nonclassical Antifolates: Synthesis and Preliminary Biological and Structural Evaluation

Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase

Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase

Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene

Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy

SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations

A long-acting suicide gene toxin, 6-methylpurine, inhibits slow growing tumors after a single administration

Lactose in drugs: avoided or allowed to lactose maldigesters? authors’ reply

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase

DESIGN AND EVALUATION OF 5′-MODIFIED NUCLEOSIDE ANALOGS AS PRODRUGS FOR AN E. COLI PURINE NUCLEOSIDE PHOSPHORYLASE MUTANT

Antimitotic agents: structure-activity studies with some pyridine derivatives

Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)

Preclinical antitumor activity of bizelesin in mice

Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain

Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis

Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia

Antitumor activity of 2-chloroethyl (methylsulfonyl)methanesulfonate (clomesone, NSC 338947) against selected tumor systems in mice

Suchergebnisse filtern